Drug Type Targeted protein degraders |
Synonyms JPX 1185 |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors), STAT5 transcription factor inhibitors(STAT5 transcription factor inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | - | |
Solid tumor | Preclinical | US | - |